Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease


Eren F., Kurt R., Ermis F., Atuğ Ö., Imeryuz N., Yılmaz Y.

Clinical Biochemistry, vol.45, pp.655-658, 2012 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 45
  • Publication Date: 2012
  • Doi Number: 10.1016/j.clinbiochem.2012.03.019
  • Journal Name: Clinical Biochemistry
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.655-658
  • Keywords: Fibroblast growth factor 19, Nonalcoholic fatty liver disease, Hepatocyte ballooning, Enzyme-linked immunosorbent assay, INSULIN-RESISTANCE, METABOLIC SYNDROME, FGF19, STEATOHEPATITIS, MICE